The 2024 International Biomedical Industry Innovation Conference Beijing Forum opened in Beijing yesterday, aiming to foster new quality productive forces in the pharmaceutical and healthcare industry.

Yin Li, secretary of the Communist Party of China Beijing Municipal Committee, highlighted the Chinese capital’s commitment to advancing biomedicine development, emphasizing the importance of innovation and international cooperation. He outlined Beijing's strategic advantages, including its world-class health care system, medical institutions and leadership in patents and drug approvals.

Beijing recently launched 32 measures to accelerate innovation and aims to establish a globally influential biomedicine cluster, focusing on technological advancements and collaboration.

Zeng Yixin, deputy director of the National Health Commission (NHC), underscored the importance of the biopharmaceutical industry in improving public health.

During the conference, eight foreign pharmaceutical companies were offered a comprehensive suite of services to support their operations and enhance collaboration in Beijing.

Related

Go to Forum >>0 Comment(s)